Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD

Aliment Pharmacol Ther. 2012 Sep;36(5):499-500; author reply 501. doi: 10.1111/j.1365-2036.2012.05204.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / immunology*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal, Humanized / immunology*
  • Autoantibodies / blood*
  • Female
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Male
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Autoantibodies
  • Tumor Necrosis Factor-alpha